Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
European Journal of Pharmacology|December 26, 2024
Vodobatinib overcomes cancer multidrug resistance by attenuating the drug efflux function of ABCB1 and ABCG2Yen-Ching Li, Bing-Huan Lin, Megumi Murakami, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2024
The colony-stimulating factor-1 receptor inhibitor edicotinib counteracts multidrug resistance in cancer cells by inhibiting ABCG2-mediated drug effluxYen-Ching Li, Yun-Chieh Lee, Megumi Murakami, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 10, 2024
Epertinib counteracts multidrug resistance in cancer cells by antagonizing the drug efflux function of ABCB1 and ABCG2Bing-Huan Lin, Yen-Ching Li, Megumi Murakami, et al.
International Journal of Molecular Sciences|May 25, 2024
ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer CellsChung-Pu Wu, Cheng-Yu Hung, Megumi Murakami, et al.
Nature Communications|November 6, 2023
Heterojunction formed via 3D-to-2D perovskite conversion for photostable wide-bandgap perovskite solar cellsJin Wen, Yicheng Zhao, Pu Wu, et al.
Molecular Pharmaceutics|September 6, 2014
Overexpression of human ABCB1 in cancer cells leads to reduced activity of GSK461364, a specific inhibitor of polo-like kinase 1Chung-Pu Wu, Sung-Han Hsiao, Shi-Yu Luo, et al.
Pageof 17